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Serum from Mycobacterium bovis BCG-infected mice treated with lipopoly-
saccharide was cytotoxic to tumor cells in vitro. Serum-induced cytotoxicity was
estimated by measuring release of [3H]thymidine into culture supernatants of
prelabeled tumor target cells. Serum from BCG-infected mice not treated with
lipopolysaccharide or from uninfected mice treated with lipopolysaccharide was
inactive. Moreover, although serum cytotoxic activity was evident with 10 syn-
geneic or allogeneic tumor cell lines, little or no effect was observed with normal
embryonic fibroblast target cells. Maximal titers of serum cytotoxic activity were
detected 14 days after BCG infection and 2 h after LPS treatment. Serum of
BCG-infected, T-cell-deficient nude mice developed strong cytotoxic activity after
LPS treatment; however, lipopolysaccharide-insensitive C3H/HeJ mice could
produce this cytotoxic activity only after adoptive transfer with lipopolysaccha-
ride-responsive C3H/HeN bone marrow. Physicochemical characterization of the
serum cytotoxic activity revealed a heat-stable (56°C, 30 min) entity with a
molecular weight of about 60,000 and an isoelectric point at pH 4.8. Biological
and physicochemical characteristics of this serum cytotoxic activity as defined by
an in vitro assay were very similar to characteristics of tumor necrosis factor and
suggest that this molecule may be a major effector mechanism for the antitumor
actions of lipopolysaccharide.
The antitumor effects of bacterial lipopolysac-
charides (LPSs) have been the subject of re-
search for almost a century (6, 23). Transplant-
able syngeneic tumors growing intradermally or
subcutaneously can be completely cured with a
single but sometimes lethal injection of LPS at
a distant site (20). This effect was quite dra-
matic. Within 6 to 8 h of the LPS injection,
erythema developed at the tumor site. By 24 h,
extensive hemorrhagic necrosis was evident, and
by 48 to 72 h most of the tumor mass had been
sloughed (2).
Recently, Carswell et al. discovered that the
tumor necrotic action of LPS was not a direct
effect of LPS on tumor cells but rather was
mediated by a factor present in sera of LPS-
treated animals (5). A similar factor could be
isolated from sera of LPS-treated mice and rab-
bits without tumors but previously injected with
Mycobacterium bovis strain BCG (10, 14). The
tumor necrosis activity of serum from LPS-
treated animals could be separated from many
of the toxic effects of LPS itself (10). Moreover,
although tumor cells of different origins were
inhibited or killed by this tumor necrosis factor
in vitro, normal embryonic fibroblasts were un-
affected under the same conditions (5, 11, 19).
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Based on these earlier observations, we have
developed a sensitive and quantitative in vitro
assay for cytotoxic factors in the sera of LPS-
treated animals. In a previous communication
we used this assay to discriminate the cytotoxic
factor from lymphocyte-activating factor which
appears in BCG-infected mice after LPS injec-
tion (13). In this report, conditions for optimal
release of cytotoxic factors in sera of BCG-in-
fected mice and physicochemical characteriza-
tion of the active factor are presented.
MATERIALS AND METHODS
Mice. Female C3H/HeN mice, 6 to 12 weeks of age,
were obtained from the Division of Research Services,
National Institutes of Health. C3H/HeJ mice were
purchased from the Jackson Laboratory, Bar Harbor,
Maine.
LPS. Escherichia coli K235 LPS was prepared by
the phenol-water extraction method of McIntire et al.
(16) or by the butanol extraction procedure described
by Morrison (17). Salmonella Minnesota Re mutant
R595 LPS isolated by phenol-chloroform-petroleum
ether method (8) was a generous gift of E. T. Rietschel,
MPI, Freiburg, West Germany. Polysaccharide of S.
Minnesota (Freeman type [7]) was kindly given by C.
Bona, NIH, Bethesda, Md. The phenol-water-ex-
tracted LPS of E. coli K235 was used for most of the
studies.
Preparation of cytotoxic serum. Mice were in-
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fected intravenously (i.v.) with 2 x 10" colony-forming
units (CFU) ofliving Mycobacterium bovis strain BCG
(Phipps substrain TMC no. 1029, Trudeau Mycobac-
terial Collection, Saranac Lake, N.Y.), and then were
injected i.v. 14 days later with 10,jg of LPS. Two hours
after LPS injection, the animals were exsanguinated,
and the serum was prepared (BCG-LPS serum). Con-
trol serum was obtained from LPS-injected normal
mice in a similar manner. All sera were stored at
-20'C until use.
Cytotoxicity assay. Tumor cells (mouse L 929,
ATCC) at 4 x 104 cells per 16-mm culture well (Costar
24, Cambridge, Mass.) were labeled in 0.5 ml of Eagle
minimal essential medium (EMEM) with 25 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesul-
fonic acid) buffer, 5% heat-inactivated fetal calf serum
(FCS), and 0.5 1LCi of [3H]TdR ([methyl-3H]thymidine,
specific activity, 1.9 Ci/mmol; Schwarz/Mann, Or-
angeburg, N.Y.) for 18 to 24 h. Tumor cell monolayers
were washed twice after labeling and incubated in
dilutions of cytotoxic serum in 1 ml of Dulbecco MEM
containing 10% FCS and 50 1g of gentamicin/ml. La-
beled tumor cell monolayers lysed with 0.5% sodium
dodecyl sulfate in water were used to estimate total
incorporated counts per minute (cpm). For some ex-
periments, the identical procedure was carried out in
0.4-mm flat-bottom culture wells (Costar 96, Cam-
bridge, Ma.) with 4 X 103 cells per well in 0.2 ml of
medium. Tumor cytotoxicity was estimated by meas-
uring the release of incorporated [3H]TdR from the
labeled tumor cells in duplicate cultures and expressed
as mean cpm ± standard deviation or as specific re-
lease according to the formula (experimental cpm -
cpm of control)/(cpm of sodium dodecyl sulfate - cpm
of control) x 100. Cells were counted in a Coulter
Counter (model ZBI, Coulter Electronics, Inc., Hi-
aleah, Fla.) in quadruplicate after treating adherent
cells with 0.5% trypsin-0.2% ethylenediaminetetraace-
tic acid (EDTA) solution and suspending them in
Isotone II (Coulter Electronics) containing 10% FCS.
Chromatographic procedures. Samples were
subjected to gel filtration on a Sephacryl S-200 column
(2.6 by 90 cm) equilibrated in pH 7.5 buffer containing
0.05 M tris(hydroxymethyl)aminomethane (Tris), 0.1
M sodium chloride, or 1.6 M sodium chloride. All
chromatography was performed at 4°C at a flow rate
of approximately 12 ml/h. Up to 10 ml of either
unfractionated serum or the ammonium sulfate pre-
cipitate, dialyzed 4 times against pH 7.5 Tris buffer
adjusted to a final volume of 6 ml in the same buffer,
was applied to the column. Fractions of approximately
3 ml were collected, and portions were sterilized by
Millipore filtration before they were tested in the
cytotoxicity assay. Up to 10 ml of unfractionated se-
rum was applied on a column (1 by 30 cm) of diethyl-
aminoethyl (DEAE)-Sephacel (Pharmacia) equili-
brated in 0.05 M Tris buffer (pH 7.1). The column was
washed with 4 column volumes of starting buffer be-
fore initiation of a linear 0 to 400mM sodium chloride
gradient (total gradient volume 280 ml). The flow rate
was approximately 12 ml/h. Fractions (2 ml) were
collected, and portions were prepared for the cytotox-
icity assay. The sodium chloride content of the column
fractions was determined with an Osmometer (model
3L, Advanced Instruments, Inc., Newton Highlands,
Ma.).
A 0.5-ml amount of unfractionated BCG-LPS serum
was applied to a 5-mm-thick bed of Sephadex G75
Superfine with 5% Pharmalyte (Pharmacia) (pH 4 to
6.5) and focused for 18 h at a constant power of 1 W
on a flatbed apparatus (LKB 2117 Multiphor). The
fractions were eluted with 6 ml of phosphate-buffered
saline. After we measured the pH of individual frac-
tions, we dialyzed the fractions against phosphate-
buffered saline for 24 h, sterilized them by filtration,
and assayed them for tumor cytotoxicity.
Induction of tumors and in vitro culture of
tumor cells. Fibrosarcomas were induced intrader-
mally in mice with 1 mg of 3-methylcholanthrene in
0.2 ml of trioctanoin (tricaprylin, Sigma Chemical Co.,
St. Louis, Mo.). For in vitro culture, solid tumor pieces
were minced and a single cell suspension was obtained
by enzymatic digestion (3). The cells were cultured in
EMEM containing 10% FCS and 50,g of gentamicin
per ml.
Generation of chimeric mice. Bone marrow cells
were obtained by gently grinding and then rinsing
femura and tibiae of donor mice in cold RPMI medium
(GIBCO Laboratories, Grand Island, N.Y.). Bone frag-
ments were removed by being allowed to settle for 5
min; the cells were washed and then suspended in
medium to a concentration of 10" cells/ml. Cell viabil-
ity exceeded 90% as determined by exclusion of trypan
blue dye. Mice received 850 roentgens of X-irradiation
and were reconstituted within 6 h by tail vein injection
of 107 bone marrow cells. Three days before and for 2
weeks after reconstitution, the mice were given drink-
ing water containing 1 g each of ampicillin (Totacillin-
N, Beecham Laboratories, Bristol, Tenn.), carbenicil-
lin (Pyophen, Beecham Laboratories), and cephalo-
thin (Keflin, Eli Lilly & Co., Indianapolis, Ind.) per
liter. Four to 6 weeks after reconstitution, the mice
were used in the experiments.
RESULTS
In vitro detection of cytotoxic factors in
serum of BCG-infected mice treated with
LPS. Serum of BCG-infected mice treated with
LPS (BCG-LPS serum) contained factors cyto-
toxic for tumor cells in vitro (Table 1). Cytotox-
icity was detected with each of 10 different mu-
rine fibrosarcomas after treatment with 1/100
dilution of BCG-LPS serum. The same dilution
of serum had little or no effect on syngeneic
embryo fibroblasts. It is important to note that
fibrosarcomas from lipid A-unresponsive C3H/
HeJ mice were as susceptible to the active serum
as fibrosarcomas from normally responsive
C3H/HeN mice. That there was no difference in
susceptibility between tumors of LPS-respon-
sive and -unresponsive strains suggests that a
direct effect of LPS upon target cells was un-
likely. Among the tumors assayed, the C3H/
HeN fibrosarcoma L 929 was the most sensitive
target cell and was therefore used in all further
studies. Serum from BCG-infected mice not
treated i.v. with LPS, or from normal mice with
or without LPS treatment, had no effect on
either normal or tumor cells. LPS in medium up
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to a concentration of 100 tug/ml was also without
effect (data not shown).
Release of radiolabel from [3H]TdR-prela-
beled L 929 cells into culture supernatants at 48
h showed an inverse correlation with the number
of intact cells estimated by direct cell counts
(Fig. 1). Significant cytotoxicity to L 929 cells by
BCG-LPS/sera could be detected with as little
as a 1/1,000 dilution. Cytotoxic activity, how-
ever, even at the higher serum concentration,
was dependent on continuous presence of the
cytotoxic factor (Fig. 2). Target cells incubated
with a 1/100 dilution of active serum for up to 8
TABLE 1. Tumor cytotoxic activity of BCG-LPS
serum and normal mouse seruma
BCG-LPS NormalTarget cell serumh mouse
serum
C3H/HeN fibrosarcoma
L929 55 ± 2 0 ±1
Tumor A 19±1 1± 0
TumorB 19 ± 0 0 ± 1
Tumor C 13 ± 1 0 ± 0
Tumor D 12 ± 1 0 ± 0
C3H/HeJ fibrosarcoma
Tumor A 20 ± 2 0 ± 1
Tumor B 17 ± 1 1 ± 0
Tumor C 12 ± 1 2 ± 1
Tumor D 10 ± 1 0 ± 1
TumorE 10±0 1±0
Embryo fibroblasts 3 ± 0 0 ± 0
a Each value represents percent specific label re-
lease ± standard deviation.
'BCG-LPS serum and normal mouse serum were
diluted 1/100.
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FIG. 1. Tumor cytotoxicity dose response ofBCG-
LPS serum and normal mouse serum. [3H]TdR-la-
beled or unlabeled L 929 cells were incubated in
different dilutions ofBCG-LPS serum ( ) or nor-
mal mouse serum (- ) for 48 h. Tumor cytotox-
icity was estimated by [3H]TdR release (total incor-
porated cpm = 45 x 103) (0) and by counting intact
cells on a Coulter Counter (A). More than 95% of the
recovered cells were viable as determined by trypan
blue dye exclusion.
h and then washed, released little or no radio-
label at 48 h. Even a 24-h pulse with cytotoxic
factor was less efficient than continuous pres-
ence throughout the assay.
Optimal conditions for the in vivo pro-
duction of cytotoxic factors in serum of
BCG-infected mice treated with LPS. Mice
were treated i.v. with LPS at various times after
BCG infection (Fig. 3). Tumor cytotoxic factors
were detected in the serum of BCG-LPS mice
by 1 week but not 3 days after BCG infection.
Maximal production was evident at 2 weeks and
then progressively declined to about control lev-
els by 8 weeks.
The time course for appearance of cytotoxic
factors in serum of BCG-LPS mice is shown in
Fig. 4. Cytotoxic activity was detected 30 min
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FIG. 2. Tumor cytotoxicity after exposure to LPS-
BCG serum or normal mouse serum for various times.
[3H]TdR-labeled L 929 cells were incubated with a
1/100 dilution of BCG-LPS serum ( ) or normal
mouse serum (---- ) for 0 to 48 h. The supernatant
was replaced by fresh medium without mouse serum,
and cytotoxicity was estimated by [3H]TdR release
at 48 h (total incorporated cpm = 40 x 103).
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FIG. 3. Kinetics of the appearance of cytotoxic se-
rum activity duringBCG infection. Mice were infected
i.v. with 2 x 106 CFU ofBCG and injected i.v. with 10
pg ofLPS after 3 days and after 1, 2, 4, and 8 weeks.
Two hours after LPS injection, the animals were bled
and serum wasprepared. Tumor cytotoxicity ofBCG-
LPS serum ( ) and BCG serum ( - - - ) was
estimated by [3H]TdR release of labeled L 929 cells
at 48 h (total incorporated cpm = 60 x 103).
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after LPS injection, reached maximal levels by
1 to 2 h, and then progressively declined and
was absent by 6 h. A second injection of LPS 6
h after the first injection failed to induce reap-
pearance of tumor cytotoxic activity.
Cytotoxic activity in serum of BCG-LPS mice
was dependent upon a sufficient dose of phenol-
extracted LPS. Maximal activity occurred after
1 ,ug of LPS (Fig. 5). Cytotoxic activity could be
detected in BCG-injected mice after treatment
with polysaccharide-deficient LPS of S. minne-
sota R 595 (Re mutant), suggesting that the
active principle of LPS was lipid A (Table 2).
This is further confirmed by the fact that the
polysaccharide part of LPS (Freeman type [7])
or a second antigenic stimulus such as purified
protein derivative (PPD) was unable to induce
(vtotoxic serum activity in the BCG-infected
°x_ 20 _
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FIG. 4. Kinetics of the appearance of cytotoxic se-
rum activity after LPS injection of BCG-infected
mice. Mice were infected i.v. with 2 x 106 CFU of
BCG and injected i.v. with IOAg ofLPS 2 weeks later.
After 10 and 30 minutes and after 1, 2, 4, 6, and 8 h,
animals were bled and serum was prepared. Tumor
cytotoxicity with 1/100 dilution of the sera was esti-
mated by [3H]TdR release of labeled L 929 cells at
48 h (total incorporated cpm = 50 x i03).
mice. In addition, lipid A-unresponsive C3H/
HeJ mice failed to produce serum cytotoxic fac-
tors after the BCG-LPS treatment. C3H/HeJ
mice treated with BCG and butanol-extracted
LPS also failed to produce serum cytotoxic ac-
tivity. Butanol-extracted LPS is a strong B cell
mitogen even for the lipid A-unresponsive C3H/
HeJ mouse (9).
C3H/HeJ mice could produce cytotoxic fac-
tors only after adoptive transfer of lipid A-re-
sponsive C3H/HeN bone marrow (Table 3). Au-
tologous transfer of bone marrow cells into ir-
radiated C3H/HeJ or C3H/HeN recipient mice
did not alter their responsiveness to LPS. How-
ever, irradiated C3H/HeN recipients treated
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FIG. 5. LPS dose response for induction of cyto-
toxic serum factor. Mice were infected i.v. with 2 x
106 CFU of BCG and injected i.v. with 0.001 to 100
pg ofLPS 2 weeks later. After 2 h, animals were bled
and serum was prepared. Tumor cytotoxicity with a
1/100 dilution of the sera was estimated by [3H]TdR
release of labeled L 929 cells at 48 h (total incorpo-
rated cpm = 35 x 103).
TABLE 2. Tumor cytotoxic activity in serum of untreated or BCG-infected mice challenged with different
stimuli
C3H/HeN C3H/HeJ
Challenge'
Untreated BCG infected Untreated BCG infected
Ph-LPS 1,500 ± 150 28,300 ± 50 2,050 ± 50 1,850 ± 100
Bu-LPS 1,550 ± 50 26,450 ± 900 1,600 ± 100 1,550 ± 150
R 595-LPS 1,500 ± 50 25,700 + 850 1,450 ± 50 1,850 ± 300
PS 2,050 ± 150 1,950 ± 200 1,400 ± 500 1,500 ± 50
BCG 1,850 ± 150 1,600 ± 50 1,650 ± 50 1,950 ± 100
PPD 1,650 ± 300 1,700 + 50 1,600 ± 50 1,550 ± 100
a Each value represents cpm ± standard deviation.
b C3H/HeN or C3H/HeJ mice infected with 2 x 106 CFU ofBCG for 2 weeks were challenged intraperitoneally
with 50 ug of phenol-extracted E. coli K 235 LPS (Ph-LPS), 50 Ag of butanol-extracted E. coli K 235 LPS (Bu-
LPS), 10 pg of phenol-extracted S. minnesota R 595 LPS, 50 jg of polysaccharide from S. minnesota (PS), 2 x
106 CFU of BCG, or 100 jg of purified protein derivative (PPD). After 2 h, animals were bled and sera were
prepared. Tumor cytotoxicity was estimated by [3H]TdR release of labeled L 929 cells after 48 h of culture in
a 1/100 dilution of the sera (total incorporated cpm = 50 X 103).
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with nonresponsive C3H/HeJ bone marrow
failed to produce cytotoxic serum activity after
LPS challenge. Although the capacity of mice to
respond to lipid A was essential for tumor cyto-
toxic activity in the serum, there was no appar-
ent need for T cell participation. Serum of BCG-
injected mice homozygous for the nu gene (nude
mice) developed strong tumor cytotoxic activity
after intravenous LPS treatment (Table 4). Al-
though production of tumor cytotoxic activity in
the serum of LPS-treated nude mice is at vari-
ance with an earlier observation by Old (18), a
recent report by Berendt et al. showed strong
LPS-induced tumor-necrotizing effects in T cell-
deficient mice (4).
Biochemical characterization of the tu-
mor cytotoxic activity from serum. Tumor
cytotoxic activity was as follows. (i) Cytotoxic
activity was stable at 570C for more than 1 h,
and no significant loss in activity was observed
when samples were lyophilized or stored in so-
lution at 40C for several weeks.
TABLE 3. Demonstration of tumor cytotoxic factor
in serum after LPS treatment ofBCG-infected mice
No. of mice
with cytotoxic
Donor Recipient' serum factor
per no. of
mice tested
C3H/HeN C3H/HeN. 13/14
C3H/HeJ C3H/HeN. 0/18
C3H/HeJ C3H/HeJ. 0/15
C3H/HeN C3H/HeJ. 6/8
aRecipient animals received 850 roentgens of X-
irradiation before reconstitution with 107 bone marrow
cells. Six weeks after reconstitution, animals were in-
fected i.v. with 2 x 106 CFU of BCG, and 2 weeks later
they were injected i.v. with 10 ,jg of LPS. After 2 h,
mice were bled, and tumor cytotoxicity was estimated
by [3H]TdR release of labeled L 929 cells after 48 h of
culture in a 1/100 dilution of the sera.
TABLE 4. Tumor cytotoxic activity of sera from
BCG-infected C3H/HeN and nude mice challenged
with LPS'
Challenge (Mg C3H/HeNb C3H/HeN nu/nu
of LPS)
0 3,700 ± 100 2,900 ± 350
0.5 11,200 ± 550 15,700 ± 50
5 23,800 ± 850 29,800 ± 950
50 29,800 ± 700 28,500 + 950
nEach value represents cpm ± standard deviation:b C3H/HeN or C3H/HeN nu/nu mice infected i.v.
with 2 x 106 CFU of BCG for 2 weeks were injected
i.v. with 0, 0.5, 5, and 50,ug of LPS and bled 2 h later.
Tumor cytotoxic activity was estimated by [3H]TdR
release of labeled L 929 cells after 48 h of culture in a
1/100 dilution of the sera (total incorporated cpm =
56 x 103).
(ii) BCG-LPS and control sera were applied
to Sephacryl S-200 columns and eluted with Tris
buffer containing 0.1 M sodium chloride. The
elution profile showed one major peak; cytotoxic
activity was found at an apparent molecular
weight of 150,000. Control serum fractions had
little or no cytotoxic activity. Most of the cyto-
toxic activity in serum was found in the precip-
itate of a 40 to 60% saturated ammonium sulfate
solution. The ammonium sulfate precipitate was
chromatographed as described above (Fig. 6A).
Again, major cytotoxic activity was found in the
immunoglobulin G range; however, a second
peak with an apparent molecular weight ofabout
55,000 to 60,000 was also detected. Fractions of
LPS-induced control serum were inactive. Re-
chromatography ofthe same ammonium sulfate-
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FIG. 6. Sephacryl S-200 chromatography of am-
monium sulfate-precipitated cytotoxic activity from
BCG-LPS serum. Material precipitated with 40 to
60% ammonium sulfate saturation from 2 ml ofBCG-
LPS serum was subjected to Sephacryl S-200 col-
umns. The columns were 2.6 by 90 cm, and the flow
rate was approximately 12 ml/h. The columns were
equilibrated and eluted with 0.05 M Tris buffer (pH
7.5) containing 0.1 M sodium chloride (A) or 1.6 M
sodium chloride (B). Tumor cytotoxicity of a 1/50
dilution of the 3-ml sterile filtered fractions was es-
timated by [3HJTdR release of labeled L 929 cells at
48 h. Total incorporated cpm = 35 x 102 (A), 30 x 102
(B).
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precipitated material on an identical column but
with a buffer of higher sodium chloride content
(1.6 M) shifted the elution of cytotoxic activity
to a single peak at 55,000 to 60,000 (Fig. 6B). In
a previous study, we reported these dissociating
conditions in more detail, and the effect has
been used to separate lymphocyte-activating
factor from cytotoxic activity (13).
(iii) Tumor cytotoxic serum or control serum
was applied to diethylaminoethyl-Sephacel col-
umns and washed with Tris buffer (pH 7.1). A
gradient was started from 0 to 0.4 M sodium
chloride. Cytotoxic activity in BCG-LPS serum
eluted from the column at a 0.17 to 0.2M sodium
chloride concentration (Fig. 7). No cytotoxic ac-
tivity was detected in LPS-induced control se-
rum fractions. Pooled fractions containing cyto-
toxic factor were then applied to a Sephacryl S-
200 column after extensive dialysis and lyophi-
lization and chromatographed in Tris buffer con-
taining 0.1M sodium chloride. Cytotoxic activity
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FIG. 7. DEAE-Sephacel chromatography ofBCG-
LPS serum. A 2-ml amount of unfractionated serum
was applied on a column (1.5 by 30 cm) of DEAE-
Sephacel equilibrated in 0.5 M Tris buffer (pH 7.5).
The column was washed with 4 column volumes of
starting buffer before initiation of a 0 to 400 mM
sodium chloride gradient (total gradient volume was
280 ml). The flow rate was approximately 12 ml/h.
Fractions (2 ml each) were collected and sterile fil-
tered. Tumor cytotoxicity of a 1/10 dilution of the
fractions was estimated by [3HJTdR release of la-
beled L 929 cells at 48 h (total incorporated cpm = 50
X 103). The molarity of the fractions was determined
with an osmometer.
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eluted as a single peak at an apparent molecular
weight of 55,000 to 60,000.
(iv) A 0.5-ml amount of unfractionated BCG-
LPS serum was subjected to flatbed electrofo-
cusing in a pH gradient from 4 to 6.5. Cytotoxic
activity was recovered from the fraction eluates
in a single peak together with serum albumin at
about pH 4.8 (Fig. 8); yield was less than 5% of
that applied, explanable in part by the instability
of activity below pH 6 (data not shown).
DISCUSSION
Discovery of soluble mediators in sera of
BCG-infected mice treated with microgram
quantities of LPS that reproduced tumor ne-
crotic actions of milligram quantities of LPS in
noninfected animals was an important advance
in the analysis of the antitumor properties of
bacterial endotoxin (5).
Characterization of these soluble mediators
(tumor necrosis factors) promised the opportu-
nity of separating, for the first time, the thera-
peutic action of LPS from the toxic and often
lethal side effects. Fulfillment of this promise,
however, was impeded by a difficult and impre-
cise in vivo assay.
Serum-induced necrosis of an intradermal tu-
mor transplant required large volumes of active
serum (0.5 ml per mouse), and the extent of the
tumor necrosis endpoint was dependent upon
location, size, and vascularization of the tumor
(18).
We have described in this report a sensitive
and quantitative in vitro assay to detect cyto-
toxic mediators in sera of LPS-treated, BCG-
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FIG. 8. Electrofocusing ofBCG-LPS serum. A 0.5-
ml amount of unfractionated BCG-LPS serum was
focused on a flatbed of Ultrodex with 5% Pharmalyte
(pH 4 to 6.5) for 18 h. Fractions were removed and
eluted with 6 ml of phosphate-buffered saline and
dialyzed, and the tumor cytotoxicity ofa 1/20 dilution
of the fractions was estimated by ['H]TdR release of
labeled L 929 cells at 48 h (total incorporated cpm =
35 x 102).
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infected mice; cytotoxic activity in serum can be
reproducibly detected through a 1/1,000 dilu-
tion, and the cytotoxic endpoint is now defined
by release of [3H]TdR from prelabeled target
cells instead of subjective grading for tumor
necrosis.
Properties of cytotoxic factors in serum by the
in vitro assay were very similar to those oftumor
necrosis factor as defined by the in vivo assay.
(i) The time course for optimal production of
tumor necrosis factor and for cytotoxic serum
activity (intervals between BCG infection and
LPS treatment and between LPS treatment and
serum collection) was identical (5).
(ii) Production of tumor necrosis factor and
cytotoxic serum activity were both dependent
upon normal LPS responsiveness; LPS-insensi-
tive C3H/HeJ mice or X-irradiated LPS-sensi-
tive C3H/HeN chimeric mice reconstituted with
C3H/HeJ bone marrow failed to produce either
activity after LPS challenge (13a).
(iii) The in vivo tumor necrotic action of LPS
was evident in mice homozygous for the nu gene
(data not shown); serum from LPS-treated,
BCG-infected nude mice was also cytotoxic to
tumor target cells in vitro.
(iv) Physicochemical characterization of
mouse tumor necrosis factor reveals a heat-sta-
ble activity with an apparent molecular weight
of 150,000 (10). A recent report of a similar
tumor necrotic factor of rabbit origin, however,
described activity with an apparent molecular
weight of about 50,000 (14). This conflict in
apparent molecular weight of mouse and rabbit
tumor necrosis factor(s) could be explained by
species differences. Our results, however, suggest
an alternative explanation; mouse tumor necro-
sis factor may exist as an aggregate in serum.
Cytotoxic activity of active serum, as previously
described by Carswell et al. (10), eluted from
Sephacryl S-200 in the 125,000 to 150,000 molec-
ular weight region. Ammonium sulfate precipi-
tation of this same serum followed by gel filtra-
tion in high ionic strength buffer of the precipi-
tate (conditions favoring separation of aggre-
gates) led to elution of cytotoxic activity at
55,000 to 60,000 daltons.
Several investigators have suggested that the
cellular source of tumor necrosis factor may be
the macrophage. Indeed, soluble cytotoxic fac-
tors have been isolated from macrophage cul-
tures after a variety of in vitro treatments (1, 12,
21, 24). Matthews described a soluble cytotoxic
factor from rabbit monocytes which resembled
the rabbit serum-derived tumor necrosis factor
(15). Preliminary results from our laboratory
confirm and extend this observation. Macro-
phages from BCG-infected mice treated in vitro
with LPS release soluble cytotoxic factors within
2 h of treatment. Physicochemical characteris-
tics of this macrophage-derived cytotoxin were
very similar to those of the serum factor de-
scribed in this report. Cytotoxic factors were not
detected in fluids of LPS-treated control mac-
rophage cultures. These results suggest that the
LPS-induced release of this cytotoxin may de-
pend upon the level of macrophage activation.
Recent observations by Russel and co-workers
indicate that macrophages within growing tu-
mors are either activated or can be activated
with very small quantities of LPS (22). The
tumor necrotic action of LPS could certainly be
mediated by soluble factors released by these
intratumor-activated macrophages.
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